Systemic mastocytosis – Diagnostics – Overview of Information and Clinical Research

Systemic mastocytosis is a rare blood disorder where abnormal mast cells accumulate in various organs throughout the body, causing a wide range of symptoms that can seem unconnected. Getting the right diagnosis often takes years, as symptoms may appear vague or similar to other conditions. Understanding how doctors identify this disease and what tests are needed can help people get answers sooner and begin managing their symptoms effectively.

Introduction: Who Should Consider Diagnostic Testing

If you’ve been experiencing multiple symptoms that affect different parts of your body at the same time—such as skin rashes, stomach problems, bone pain, or repeated allergic reactions—and these symptoms don’t seem to have a clear explanation, it may be time to talk to your doctor about systemic mastocytosis.^[1] This condition is rare and affects only about 13 out of every 100,000 people worldwide, but many patients go undiagnosed for years before finding answers.^[2]

You should seek diagnostic testing if you notice several of these signs appearing together: flushing of the skin that lasts more than a few minutes, hives or rashes that come and go, persistent diarrhea or stomach pain, unexplained bone pain, severe fatigue, mood changes, or repeated episodes of anaphylaxis (a severe, life-threatening allergic reaction).^[1] People with systemic mastocytosis often describe feeling like they’re experiencing continuous allergic responses even when there’s no obvious trigger.^[2]

It’s especially important to consider testing if you’ve developed new allergies that seem to appear out of nowhere, if you’ve had multiple unexplained allergic reactions, or if you’ve been told you have allergies but standard allergy treatments don’t help your symptoms.^[5] Some people notice that certain activities or substances—like alcohol, spicy foods, temperature changes, stress, exercise, or even some medications—seem to trigger their symptoms.^[1]

⚠️ Important

Many people with systemic mastocytosis see multiple doctors across different specialties before receiving a diagnosis. The average time from first symptoms to diagnosis is about three years, with some people waiting between one and nine years. If your symptoms are ongoing and affecting multiple body systems, don’t hesitate to ask your doctor about this possibility.^[21]

Children who develop symptoms are more likely to have a form of the disease that only affects the skin, called cutaneous mastocytosis, which often improves by adolescence. In contrast, systemic mastocytosis—where abnormal mast cells affect internal organs—accounts for more than 95 percent of adult cases and usually persists for a longer time.^[4] Adults who develop new skin lesions along with other symptoms should be particularly vigilant about seeking proper evaluation.

Classic Diagnostic Methods

Diagnosing systemic mastocytosis involves several steps, beginning with a thorough medical history and physical examination. Your doctor will want to know about all your symptoms, when they started, how often they occur, and what seems to trigger them. This conversation is crucial because the pattern of symptoms across different body systems often provides the first clue to diagnosis.^[9]

During the physical examination, your doctor will carefully look at your skin for any unusual marks or rashes. One distinctive finding is called urticaria pigmentosa, which appears as raised patches of brownish skin. A simple test called Darier’s sign can help identify whether these spots are related to mast cells: when the doctor rubs or strokes the affected area, it may turn red, swell, and become itchy within minutes.^[7] This reaction happens because rubbing triggers mast cells in the skin to release histamine and other chemicals.

Blood tests are essential in the diagnostic process. One of the most important measurements is the level of tryptase in your blood. Tryptase is a substance that mast cells release, and it’s almost always secreted by these cells, making it a valuable marker for diagnosis.^[4] When mast cell numbers are abnormally high in the body, tryptase levels in the blood tend to be elevated as well. Your doctor may also order a complete blood count to check for anemia or other blood cell abnormalities, as these can sometimes occur alongside systemic mastocytosis.^[9]

If blood tests and physical findings suggest systemic mastocytosis, the next crucial step is usually a bone marrow biopsy. This procedure involves using a long needle to take a small sample of bone marrow, typically from the hip bone, after the area is numbed with local anesthetic.^[7] The bone marrow sample is then examined under a microscope to look for clusters of abnormal mast cells. Finding these characteristic clusters in the bone marrow is often what confirms the diagnosis of systemic mastocytosis.^[7]

Skin biopsies may also be performed if you have visible skin lesions. During this procedure, a small sample of skin is removed and checked for the presence of excess mast cells. This can confirm whether skin symptoms are related to mastocytosis or another condition.^[7]

Imaging studies play an important role in understanding how far the disease has spread and which organs are affected. An ultrasound scan can show whether your liver or spleen has become enlarged, which happens when abnormal mast cells accumulate in these organs.^[7] Your doctor might also order a DEXA scan, which measures bone density. This test is important because systemic mastocytosis can weaken bones, leading to osteoporosis (thinning of the bones) and an increased risk of fractures.^[7]

Additional imaging tests such as CT scans or X-rays may be used to look for bone involvement or to check other organs that might be affected. These tests create detailed pictures of the inside of your body and can reveal changes in bone structure or organ size that suggest mast cell infiltration.^[9]

Urine tests are sometimes part of the diagnostic workup as well. They can measure certain substances that mast cells produce and release into the body, providing additional evidence of abnormal mast cell activity.

Genetic Testing: The KIT D816V Mutation

One of the most important breakthroughs in understanding systemic mastocytosis is the discovery of specific genetic changes that cause the disease. In approximately 95 percent of cases, systemic mastocytosis is caused by a mutation in a gene called KIT, specifically a mutation known as KIT D816V.^[3] This genetic change is not inherited from parents; instead, it happens spontaneously during a person’s lifetime, which is why doctors call it a somatic mutation.^[6]

The KIT gene provides instructions for making a protein that acts like a switch, controlling when mast cells grow, divide, and survive. In normal circumstances, this switch turns on and off as needed. However, when the KIT D816V mutation is present, the protein becomes stuck in the “on” position. This constant activation leads to uncontrolled growth and accumulation of mast cells throughout the body.^[3]

Testing for the KIT D816V mutation is usually done on the bone marrow sample obtained during biopsy, though it can sometimes be detected in blood samples as well.^[5] Finding this mutation confirms the diagnosis and also provides important information about treatment options, as some newer medications are specifically designed to target cells with this genetic change.

Understanding whether you have the KIT D816V mutation can help your doctor predict how the disease might progress and choose the most appropriate treatment plan. The mutation is particularly important when considering advanced treatment options, as certain medications work better for patients with this specific genetic change than for those without it.^[5]

Classification and Staging

Once systemic mastocytosis is diagnosed, doctors need to determine what type you have, as this affects treatment decisions and what to expect going forward. There are five main subtypes, ranging from mild to severe.^[9] Understanding your specific type helps you and your healthcare team plan the best approach to managing your condition.

Indolent systemic mastocytosis is the most common type, accounting for about 90 percent of adult cases. In this form, symptoms usually develop slowly over several years. You might have skin involvement, and mast cells may accumulate in your liver, spleen, or digestive tract, but organ function remains relatively stable.^[2] People with indolent systemic mastocytosis generally have a normal or near-normal life expectancy.^[6]

Smoldering systemic mastocytosis represents a middle ground between indolent and more aggressive forms. With this type, you may have more organs affected and more severe features than with indolent disease. Abnormal mast cells multiply particularly in the liver and spleen, potentially causing these organs to become enlarged over time.^[2]

Systemic mastocytosis with an associated hematologic neoplasm is more complex. In this type, which affects about one-fifth of people with systemic mastocytosis, you develop not only the mast cell disease but also another blood disorder at the same time.^[2] This combination requires careful management of both conditions.

Aggressive systemic mastocytosis is a severe form where mast cells infiltrate organs to the point of causing damage and dysfunction. This type can affect your bones, making them weak and prone to fractures. It can also cause fluid to build up in the abdomen, a condition called ascites, and may impair the function of the liver, spleen, or lymph nodes.^[6]

Mast cell leukemia is the rarest and most aggressive type. In this form, large numbers of abnormal mast cells circulate in the blood, similar to what happens in other types of leukemia. It’s extremely serious and associated with a shortened life expectancy.^[2]

To determine which type you have, doctors look at several factors: how many organs are affected, whether those organs are functioning properly, the number and distribution of mast cells in your bone marrow, and whether there are any other blood disorders present. This classification process involves carefully reviewing all your test results together.^[9]

Diagnostics for Clinical Trial Qualification

If you’re considering participating in a clinical trial for systemic mastocytosis, you’ll need to undergo additional testing beyond the standard diagnostic workup. Clinical trials have specific criteria for who can enroll, and these criteria help researchers ensure that study results are reliable and that participants are appropriate for the experimental treatment being tested.

Confirming the presence of the KIT D816V mutation is often essential for enrollment in clinical trials testing new targeted therapies. Since this mutation is present in approximately 95 percent of systemic mastocytosis cases, many trials specifically recruit patients who have this genetic change.^[5] Your study team will need documentation of your mutation status from genetic testing performed on your bone marrow or blood sample.

Clinical trials typically require fresh bone marrow biopsies performed within a certain timeframe before enrollment, even if you’ve had one done previously for your initial diagnosis. This ensures that researchers have current information about your mast cell burden and the characteristics of these cells. The bone marrow sample will be analyzed not only for the presence of abnormal mast cells but also for specific features that help classify your disease subtype.^[7]

Baseline measurements of organ function are crucial for trial participation. Before starting any experimental treatment, doctors need to know how well your organs are working so they can monitor for changes during the trial. This usually includes blood tests to assess liver and kidney function, heart tests such as an electrocardiogram or echocardiogram, and pulmonary function tests to measure lung capacity.^[9]

Imaging studies provide important baseline information about organ involvement and size. You may need CT scans or MRI scans to measure the size of your spleen and liver, as well as to check for any masses or abnormalities in other organs. These initial scans serve as a reference point for later comparisons to see if treatment is working.

Detailed symptom assessments are standard in clinical trials. You’ll likely be asked to complete questionnaires about your symptoms, their severity, and how they affect your daily life. These assessments help researchers measure whether the treatment improves quality of life. Some trials also require you to keep a symptom diary, recording when symptoms occur and what might have triggered them.

Blood tests in clinical trials often go beyond standard measurements. In addition to tryptase levels, researchers may measure other substances released by mast cells, such as histamine or prostaglandins. They may also monitor blood counts more frequently than in routine care to watch for any effects of the experimental treatment on blood cell production.^[4]

⚠️ Important

Clinical trials often have strict eligibility criteria regarding previous treatments. Some trials only accept patients who haven’t received certain therapies before, while others specifically look for people whose disease hasn’t responded to standard treatments. Make sure to discuss your complete treatment history with the trial team to determine if you’re eligible.

Performance status assessments evaluate how well you can carry out daily activities. Trials typically use standardized scales to measure your physical functioning, as this affects both your eligibility and the study’s ability to assess treatment effects. Being honest about your capabilities helps ensure your safety during the trial.

Some trials require documentation of specific symptoms or complications. For example, if a study is testing a treatment for anaphylaxis prevention, you may need documented evidence of previous anaphylactic episodes. If the trial focuses on bone involvement, you might need bone density scans and documentation of fractures or bone pain.

Prognosis and Survival Rate

Prognosis

The outlook for people with systemic mastocytosis varies greatly depending on which type of the disease you have. Those with indolent systemic mastocytosis, the most common form, typically have a normal or near-normal life expectancy.^[6] Many people with this type can live for decades with their condition, managing symptoms with medications and lifestyle adjustments. The disease may remain stable for years, though in some cases it can slowly progress over time.

For smoldering systemic mastocytosis, the prognosis is also generally favorable, though symptoms may be more significant than in the indolent form. This type can sometimes progress to more aggressive forms, which happens in approximately 9 percent of cases.^[5] Regular monitoring helps doctors catch any changes early so they can adjust treatment accordingly.

The more severe forms of systemic mastocytosis carry a more serious prognosis. Aggressive systemic mastocytosis and systemic mastocytosis with associated blood disorders typically involve a shortened life expectancy, though this varies considerably among individuals.^[6] People with these advanced forms usually survive months to a few years after diagnosis, depending on how well they respond to treatment and which organs are affected.

Mast cell leukemia, the rarest and most aggressive form, has the most challenging prognosis. This type progresses rapidly and is associated with severe complications. However, even with advanced disease, treatment can help manage symptoms and improve quality of life for the time remaining.^[2]

Several factors influence prognosis beyond just the disease subtype. Younger age at diagnosis, fewer organs involved, and the absence of certain genetic markers are generally associated with better outcomes. Having additional blood disorders alongside systemic mastocytosis typically worsens the prognosis. Your response to initial treatment also provides important information about your likely disease course.^[6]

Survival Rate

Survival rates for systemic mastocytosis differ dramatically between the non-advanced and advanced forms of the disease. People with non-advanced systemic mastocytosis, which includes indolent and smoldering types, generally have survival rates similar to the general population. The indolent form may progress to more severe types in approximately 5 percent of cases, which affects long-term survival for that small group.^[5]

For advanced systemic mastocytosis, survival depends on the specific subtype and how aggressively the disease behaves. Those with aggressive systemic mastocytosis typically have a survival time measured in months to a few years, though newer treatments are improving these outcomes. Systemic mastocytosis with an associated blood disorder has variable survival depending on what the associated condition is and how both diseases respond to treatment.^[6]

Mast cell leukemia has the poorest survival rate among all forms of systemic mastocytosis, with most patients surviving less than a year from diagnosis. However, this is the rarest form, affecting very few people with the condition.^[2]

It’s important to remember that survival statistics represent averages from groups of patients and cannot predict what will happen to any individual person. Factors such as overall health, age, access to specialized care, and how well you respond to treatment all play important roles in determining outcomes. Advances in treatment, particularly newer targeted therapies, are continuously improving survival for people with more aggressive forms of the disease.

#1 Clinical Trials Search in Europe